Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00072761 · ClinicalTrials.gov registry record · Phase 3
Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial
A Phase 3 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 3
- Development phase
- 196
- Enrollment target
NCT00072761 is a Phase 3 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 196 participants.
The verdict
NCT00072761, a Phase 3 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 196 participants
- Enrollment target
Study Summary
The goal of this study is to determine the effectiveness of blood transfusion therapy for prevention of silent cerebral infarct (stroke) in children with sickle cell anemia.
Interventions
- PROCEDURE transfusion therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 196 participants |
| Start Date | 2004-12 |
| Est. Completion | 2013-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00072761
The ClinicalTrials.gov registry entry for NCT00072761 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which transfusion therapy is the first listed.
NCT00072761 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00072761 about?
NCT00072761 is a clinical study titled "Silent Cerebral Infarct Transfusion Multi-Center Clinical Trial". The goal of this study is to determine the effectiveness of blood transfusion therapy for prevention of silent cerebral infarct (stroke) in children with sickle cell anemia.
What is the current status of trial NCT00072761?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 196 participants. The study started on 2004-12. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00072761?
The interventions under investigation include: transfusion therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00072761?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.